Home       About             Help       Phenotype data > NON/ShiLtJ strain > cell and tissue damage Options: apoptosis chromosome instability all Focus: all Measurements: About these NON/ShiLtJ averages (♀ ♂) Exit NON/ShiLtJ mode cell and tissue damage — apoptosis         flow cytometry   Mills1 early apoptotic splenocytes [%]         • 6mo  ......       • 12mo  ...... 3.87 (N=3)   2.77 (N=3)         • 20mo  ...... 6.07 (N=3)   4.95 (N=2)           • age comparison   30 strains   ages shown   Inbred Mills1 late apoptotic splenocytes [%]         • 6mo  ......       • 12mo  ...... 5.37 (N=3)   6.30 (N=3) ▲         • 20mo  ...... 5.87 (N=3)   9.05 (N=2) ▲▲           • age comparison   30 strains   ages shown   Inbred Mills1 all apoptotic splenocytes [%]         • 6mo  ......       • 12mo  ...... 9.23 (N=3)   9.07 (N=3) ▲         • 20mo  ...... 11.9 (N=3)   14.0 (N=2) ▲           • age comparison   30 strains   ages shown   Inbred Mills1 apoptosis profiles (early, late, all)         6mo        12mo        20mo        30 strains   ages shown   Inbred   cell and tissue damage — chromosome instability         flow cytometry   Mills1 reticulocytes with micronuclei [%]         • 6mo  ......       • 12mo  ...... 0.0914   0.0935 ▲         • 20mo  ...... 0.0853 ▲   0.0670 (N=2) ▲▲           • age comparison   30 strains   ages shown   Inbred Mills1 red blood cells (RBC) with micronuclei [%]         • 6mo  ......       • 12mo  ...... 0.248   0.243         • 20mo  ...... 0.167   0.175 (N=2)           • age comparison   30 strains   ages shown   Inbred Mills1 non-nucleated peripheral blood cells with micronuclei [%]         • 6mo  ......       • 12mo  ...... 0.262   0.307         • 20mo  ...... 0.193   0.200 (N=2)           • age comparison   30 strains   ages shown   Inbred Mills1 chromosome instability profiles (retic, RBC, all)         6mo        12mo        20mo        30 strains   ages shown   Inbred

Video tutorial session 2 explains the use of this page.

Contact us About MPD Also at JAX

Units Changelog Downloads

Citing Funding Terms of Use